BELGRADE VALVE INTERNATIONAL SYMPOSIUM – BELVIS
Hotel Hilton, Belgrade, Serbia 31.05-01.05 2019
Honorary President Of The Organizing Committe
Academician Prof. Dr Vladimir Kanjuh
Organizing Committe
M.Banovic, S.Putnik, D.Kostic, I.Koncar, V.Giga, A.Djordjevic-Dikic, A.Redzek, A.Mikic
Scientific Committee
Banovic M, Beleslin B, Ivanovic B, Kacar S, Kanjuh V, Kostic T, Micovic S, Mikic A, Nedeljkovic I,
Neskovic A, Obrenovic B, Putnik S, Redzek A, Ristic A, Stankovic G, Srdanovic I, Stojanovic I, Vukcevic V.
Invited speakers:
B.Iung, France
G.McCann, Great Britain
L de Kerchofe, Belgium
B.Mimic, Great Britain
M.Deja, Poland
J.Bartunek, Belgium
G.Doros, USA
M.Penicka, Belgium
M Da Costa, Rep Ireland
K Smiris, Germany
I Medved, Croatia
SCIENTIFIC PROGRAM:
08.30-10.00 AVATAR Steering Commitee
10.00 Opening Ceremony - Moderators: M.Banovic, S.Putnik
10.10-10.25 Opening lecture: Challenges in valve disease for the next decade (B Iung, Paris, France)
Session1. 10:30-12.10
Severe aortic valve stenosis treatment: a view from different angles
Moderators: B.Obrenovic, A.Mikic, B.Beleslin
10.30-10.45 Asymptomatic severe aortic valve stenosis: the ongoing controversy (G McCann, Leicester, Great Britain)
10.50-11.05 Surgical valve treatment: choice of prosthesis and antithrombotic therapy (S Putnik, Belgrade, Serbia)
11.10-11.25 TAVI trials, TAVI candidates: contemporary results and future expectations (M Banovic, Belgrade, Serbia)
11.30-11.45 Aortic valve repair: when and how? (L de Kerchofe, Louvain, Belgium)
11.50-12.05 Aortic stenosis in children (B Mimic, Leicester, Great Britain)
12.10-12.30 Coffee break
Session2. 12.30-14.10
Mitral Valve Disease
Moderators: V.Kanjuh , B.Ivanovic, I.Stojanovic
12.30-12.45 The congenital mitral stenosis (V Kanjuh, Belgrade, Serbia)
12.50-13.05 Echocardiographic assessment of mitral regurgitation (I Nedeljkovic, Belgrade, Serbia)
13.10-13.25 When to intervene in secondary mitral regurgitation (M Deja, Katowice, Poland)
13.30-13.45 Mitraclip procedure: challenges and future trends (J Bartunek, Aalst, Belgium)
13.50-14.05 When and how to intervene in mitral valve stenosis (A Redzek, Sremska Kamenica, Serbia)
14.10-15.40 Lunch break
14.30-15.00 Lunch Symposium : Bayesian approaches to clinical trials (G Doros, Boston, USA)
15.00-15.15 Medtronic Lunch Symposium : Aortic Root Surgery and Endocarditis: Current Practice and New Techniques
15.20-15.35 Biointegral Lunch Symposium : TBA (I. Medved, Croatia)
Session3. 15.45-17.00
Valvular Heart Disease: “The Global Picture”
Moderators: A.Neskovic, T.Kostic, I.Srdanovic, T.Kacar
15.45-16.00 Aortic stenosis and coronary artery disease: How to evaluate and treatment decisions (V Vukcevic, Belgrade, Serbia)
16.05-16-20 Cardiac MRI: Advantages and defects in evaluating patients with valve disease (M Penicka, Aalst, Belgium)
16.25-16.40 Management of Infective Endocarditis (S Micovic, Belgrade, Serbia)
16.45-17.00 Management of tricuspid valve disease: when is the right time? (M Da Costa, Galway, Rep Ireland)